Prions are pathogens formed from abnormal conformers (PrP Sc
humans [1] . Prions are formed from abnormal, b-sheet enriched conformers (PrP Sc ) of the 6 host encoded cellular prion protein (PrP C ). Prions replicate by templating the conversion and 7 polymerization of PrP C by an autocatalytic process [2, 3] . Multiple strains of prions are 8 recognized phenotypically within the same host species. Strains are conformational variants 9 of PrP Sc , at the level of the tertiary and/or quaternary structure [4] [5] [6] . In the infected host, 10 prion strains exhibit specific incubation periods, stereotyped clinical signs and 11 neuropathology, and specific tropism for the central nervous system (CNS) and lymphoid 12 tissues (for review [7, 8] ). Thus, certain prions can replicate early and at fairly high levels in 13 tissues of the lympho-reticular system such as the Peyer's patches, spleen and lymph nodes 14 [9] [10] [11] . Lymphotropic prions are then transported from these early reservoirs of infectivity to 15 the brain either by the enteric nervous system (Peyer's patches) or by the peripheral nervous 16 system and the spinal cord (spleen, lymph nodes) [12] [13] [14] . After peripheral infection, the 17 presence of differentiated follicular dendritic cells (FDC) is required for efficient prion 18 replication in the lymphoid tissue and subsequent neuroinvasion [9, [15] [16] [17] [18] [19] [20] [21] . Yet, prions can 19 differ in their capacity to neuroinvade. Certain prions can persist in the lymphoid tissue 20 without accessing the CNS [22] [23] [24] [25] . Of particular concern are BSE/variant CJD prions, which 21 are suspected to accumulate in human lymphoid tissue without neuroinvasion. 1:2000 22 exposed individuals in the UK may be silent carriers in the lymphoid tissue, causing risks of 23 secondary transmission [26] . 24 9 epitope 145-152, [37]) or with 0.1 μg/ml anti-PrP 12B2 antibody (human PrP epitope 89-93, 1 epitope, [38] ) and followed by streptavidin conjugated to horseradish peroxidase (HRP) or by 2 HRP conjugated to goat anti-mouse IgG1 antibody (1/20 000 final dilution), respectively . 3 Immunoreactivity was visualized by chemiluminescence (GE Healthcare). The relative 4 amounts of PrP res glycoforms were determined by the use of GeneTools software after 5 acquisition of chemiluminescent signals with a GeneGnome digital imager (Syngene, 6 Frederick, MD). 7
Histoblot analyses 8
Brain cryosections were cut at 8-10 μm, transferred onto Superfrost slides and kept at -20 °C 9 until use. Histoblot analyses were performed as described [39] , using the 12F10 anti-PrP 10 antibody (human PrP epitope 142-160, [40] ). Analysis was performed with a digital camera 11 (Coolsnap, Photometrics) mounted on a binocular glass (SZX12, Olympus). The sections 12
presented are representative of the analysis of three brains samples. 13
Resistance to proteinase K digestion 14 20% (w/v) brain homogenates from tg338 mice infected with 127S and LA19K prions were 15 diluted at 5% in a solubilization buffer (20 mM HEPES pH 7.4, 150 mM NaCl, 5 mM EDTA, 16 1 mM DTT, 2% (w/v) dodecyl-b-D-maltoside (Sigma)) 2% N-lauryl sarcosine (Fluka), final 17 concentrations) and digested for 2h at 37°C with increasing concentrations of PK (0 to 18 10 000 µg/ml), as indicated. After digestion, the samples were diluted in equal volumes of 19
Laemmli buffer, denatured and analyzed for PrP content by western blot, as above. 20
PrP Sc degradation by primary cultured peritoneal macrophages 1
To induce the multiplication of peritoneal macrophages, healthy tg338 mice were 2 intraperitoneally injected with 3% Brewer thioglycolate broth (BD Biosciences). Three days 3 after the injection, mice were euthanized by cervical column disruption. Peritoneal lavage was 4 performed with 5 ml D-PBS (Gibco). The lavage fluid was mixed with an equivalent volume 5 of 4°C Dulbecco's Modified Eagle Medium (DMEM, Lonza) supplemented with 10% fetal 6 calf serum (FCS, Biowhitaker), streptomycin and penicillin (PS, Gibco) before centrifugation 7
at 100 x g for 5 min. Red cells were lyzed with hematolytic medium (155 mM ammonium 8 chloride, 12 mM sodium carbonate, pH 7.4). The cells were resuspended in DMEM-10% 9 FCS-PS and washed twice by centrifugation. After a live cell count, the cells were aliquoted 10 in 6-well plates (6.10 6 cells / well) and incubated at 37°C. After 24h, non-adhering cells were 11 discarded by washing the wells with D-PBS. Macrophages were exposed to brain 12 homogenates from tg338 mice infected with 127S and LA19K prions (1% (w/v) dilution in 13 DMEM-10% FCS-PS) for 24h at 37°C. After two washes in D-PBS, the cells were lyzed or 14 incubated for 9 days. At regular time points, the contents of the wells were lyzed in lysis 15 buffer (0.5% sodium deoxycholate, 0.5 Triton X-100, 50 mM Tris-HCl, pH 7,4) and 16 centrifuged for 1 min at 500 x g. The supernatants were collected and analyzed for protein 17 content (MicroBCA kit, Pierce). The equivalent of 250 µg of proteins was digested by 1µg of 18 PK for 1h at 37°C. The samples were then methanol precipitated, resuspended in Laemmli 19 buffer, denatured and analyzed for PrP res content by western blot. 20
21

Results
1
Distinct PrP res types in the brain and spleen of high-expressor mice intracerebrally 2 inoculated with LAN-like and CH1641-like sheep scrapie isolates 3
The tg338 mice overexpress the VRQ allele of ovine PrP. The PrP C levels in the brain are ~8-4 fold higher than in the sheep brain [29] . The spleen-to-brain PrP C ratio is ~1:20 in tg338, as in 5
wild-type mice [22] . We transmitted by intracerebral (IC) route 37 sheep scrapie isolates from 6 various countries and genotypes (including VRQ) to tg338 mice (details in supplemental 7 Table 1 ). The isolates were from the LAN group [29] or closely resembling to CH1641 sheep 8 scrapie isolate ([41-44], Figure S1 ). Sheep brains from the LAN group exhibit a PrP res 9 electrophoretic signature with unglycosylated fragments migrating around 21 kDa (21K-10 PrP res , Figure 1A ). These cases are composed of two prion strain types termed LA21K and 11 LA19K, which are preferentially selected in transgenic mice expressing low or high levels of 12
PrP C , respectively [29] . The CH1641-like isolates exhibit a 19 kDa signature in the brain, as 13 CH1641 (19K-PrP res , Figure 1A , Figure S1 , [42, 43] ). Initially, these isolates were found to 14 exhibit a signature similar to BSE in sheep and were termed BSE-compatible isolates (Figure 15 S1, [41]). However, transmission of CH1641-like isolates to ovine PrP mice (ARQ or VRQ 16 allele) led to isolation of prions with strain features similar to LA19K prions ([41-43] and this 17 study). For comparison, the PG127 sheep scrapie isolate ( Figure 1A) , which led to the 18 accumulation of the same prion strain type in tg338 brain and spleen was used [45] . 19
All the inoculated isolates induced a typical prion disease in tg338 mice. The PrP res 20 electrophoretic signature was compared between the brain and spleen of the same animals at 21 the terminal stage of disease, so as to determine which substrain component was preferentially 22
replicated. The results are summarized in Table 1 and a representative immunoblot is shown 23 in Figure 1A . After IC inoculation of LAN-and CH1641-like isolates, all but two tg338 brains analyzed 8 showed prominent accumulation of 19K-PrP res , as reported previously with the prototypal 9 LAN404 isolate [29] . The resulting agent was termed LA19K because of this prominent 19K-10 PrP res signature in the brain [29] . In striking contrast, nearly all the spleens analyzed exhibited 11 a 21K-PrP res signature. The distinct PrP res patterns in the brain and spleen from the same mice 12 were observed over iterative passages of brain material by IC route, as illustrated with the 13 LAN404 isolate (LA19K at the 6 th passage, Figure 1B ). 14 Transmission of sheep scrapie isolates from the LAN group occasionally led to the emergence 15 of a highly pathogenic 'mutant' designated LA21K fast in a minority of tg338 mice [29] . IC-16 inoculation of LAN-like isolates resulted in the emergence of LA21K fast in two out of the 79 17 brains analyzed (Table 1) . 18
As LA21K fast prions accumulate in tg338 mouse spleens ( Figure 1B To summarize, while IC transmission of LAN-like and CH1641-like isolates to tg338 mice 11 leads to the isolation of LA19K prions in the brain, a divergent, prominent 21K-PrP res 12 signature was observed in the spleen. This 21K-PrP res signature, also subdominant in the 13 brain, differed from that of LA21K fast, suggesting that LA21K prions replicated in the 14 spleen of the infected mice. 15
16
Co-propagation of LA19K and LA21K prion strain variants in the brain and spleen of 17
high-expressor mice 18
To substantiate the view that the 21K-PrP res signature in the spleen is associated with LA21K 19 replication and formally exclude LA21K fast replication or a tissue-specific proteolytic 20 processing of the LA19K strain type [48], we transmitted (IC route) spleen and brain extracts 21 from the same tg338 mouse infected with LA19K (3 rd passage of LAN404) to reporter tg338 22 mice. We also challenged intracerebrally low-expressor tg143 +/mice (expressing 1.5-fold 23
PrP C compared to sheep brain [29]), as they allow the dominant propagation of LA21K prions 24 in the brain [29] . The resulting disease phenotypes in the two mouse lines are summarized in 25 14 Figure 2A . In tg338 mice, the mean incubation duration (ID) was >3-fold longer with the 1 spleen than with the brain extract. The spleen ID was also 3-fold longer than LA21K fast ID 2 at the limiting dilution [6, 29] . The PrP res pattern found after inoculation of spleen material 3 was 21K in all the brains and spleens analyzed (Figure 2A-B ). The neuroanatomical 4 deposition pattern of PrP res strikingly differed after inoculation of brain and spleen. In 5 particular, numerous plaque-like PrP res deposits were seen specifically after inoculation of the 6 spleen extract ( Figure 2C ). This phenotype was reminiscent of LA21K prions [29]. Similar 7 isolation of LA21K prions in tg338 mouse brains was observed on IC transmission of spleens 8 from tg338 mice inoculated with other LAN-or CH1641-like isolates ( Figure S2 ). In tg143 +/-9 mice, the spleen and brain extracts induced a long incubation time, with a 21K-PrP res pattern. 10 Such characteristics were reminiscent of LA21K prions in these mice (Figures 2A-B 
, [29]). 11
To consolidate the view that the 19K-PrP res and the 21K-PrP res components were independent 12 replicative entities in tg338 mice, we investigated the brain versus spleen colonization 13 following IC challenge with cloned LA19K prions (double biological cloning by limiting 14 dilution at the 3 rd iterative passage of LA404 [29]). 19K-PrP res was detected in the brain 15 ( Figure 1B) , with no evidence for the co-presence of a minor 21K-PrP res signature, as assessed 16 with 12B2 antibody ( Figure 1D ). All the spleens of the terminally-sick animals were PrP res -17 negative ( Figure 1B-1D ). Reporter tg338 mice were inoculated IC with these negative spleens 18 to estimate the amount of LA19K infectivity by an incubation time bioassay. As shown in 19 Figure 2A , the spleen extracts induced disease in 2 out of 8 mice >300 days post-infection, 20
with a 19K-PrP res signature in the brain. On the basis of such ID and the low attack rate [6] , 21 the spleen of biologically cloned LA19K prions harbored 10 5 -fold less infectivity than the 22 brain. 23
Collectively, these data indicate that IC inoculation of LAN-and CH1641-like isolates to 24 tg338 mice results in the preferential replication of the LA19K and LA21K subcomponents in 25 the brain and spleen, respectively. In the brain, both LA19K and LA21K subcomponents 1 coexist, with the LA19K subcomponent in higher proportion. In the spleen, LA21K prions 2 dominate, LA19K prions being barely detectable. LA19K prions thus show a preferential 3 tropism for tg338 mouse brain. Such tissue-dependent segregation is reminiscent of the 4 diverging selection of LA19K and LA21K prions on transmission to transgenic mice 5 Table S2 ). Similarly, 24 the spleens were uniformly and early PrP res -positive following IP inoculation with the LAN-25 like and CH1641-like sheep scrapie isolates ( Figures 3A-B ). Yet, the tempo and the clinical 1 manifestation of the disease and the dominant strain type replicating in the brain were not 2 uniform amongst the mice analyzed. The mean IDs were ~3-fold longer than in the IC 3 inoculated animals, ranging from 520 to 560 days ( Figure 3A ). Twenty-four percent of the 4 brains analyzed were PrP res -negative. Fifty-nine percent of the brains exhibited a 21K-PrP res 5 pattern and sixteen percent a 19K-PrP res pattern ( Figures 3A-B ). The 21K-PrP res pattern 6 dominated over the 19K-PrP res pattern for all but one isolate (ARQ16). We conclude that IP 7 inoculation of LAN-like and CH1641-like isolates favors the neuropathological expression of 8 the splenotropic LA21K prions at the expense of LA19K prions. The significant proportion of 9 mice with no PrP res in the brain despite early, widespread accumulation of PrP res in the spleen 10 suggests a delayed efficacy of LA21K prions to replicate at full attack rate in the brain 11 following IP inoculation. 12 We studied whether changing the inoculation route similarly impacted the pathogenesis of 13 LA19K prions. Two distinct passages were used, the 4 th and the 6 th IC-brain passage of 14 LAN404. We detected an early accumulation of 21K-PrP res in all the spleen analyzed, 15
independently of the number of passages ( Figures 3A, 3C ). In the brain, the proportion of 16 Figures 3A, 3C) . These findings suggest that LA19K prions could directly 23 neuroinvade from the peripheral sites of infection, a pathway previously observed for other 24 prions in situation of impaired replication in the spleen [20, 21, 54] . However, the ID was still 25 ~2.6-fold longer than by IC route, approaching values obtained with primary sheep material 1 or uncloned LA19K prions ( Figure 3A) , indicating a delayed efficacy of LA19K prions to 2 neuroinvade from the periphery. 3 4 Preferential selection of LA21K prions on inoculation of high-expressor mice with spleen 5 material from LAN404 primary isolate 6
We asked whether a similar distinctive splenotropism between LA21K and LA19K prions 7 pre-existed in the original sheep isolate. A spleen extract from the LAN404 isolate was 8 inoculated by IC and IP routes to tg338 mice. At variance with the IC-inoculation of LAN404 9 brain material which resulted in dominant expression of LA19K prions in the brain and 10 LA21K in the spleen ([29] and Figure 4A ), IC-inoculation of LAN404 spleen material led to 11 accumulation of prions with a 21K-PrP res signature in both brain and spleen in ~450 days 12 ( Figure 4A-B) . After IP inoculation, the incubation time established at 660 days and all the 13 brains and spleens analyzed exhibited a 21K-PrP res signature ( Figure 3A-B) . To further explore the possibility that prion capacity to replicate in the spleen is controlled by 22
PrP C expression levels, we compared the replicative capacity in mice expressing low levels of 23 PrP C of two pairs of strains with opposite splenotropism in high expressors. Previously, we 24 18 reported that a pair of prion strains, designated T1 Ov and T2 Ov , isolated through the adaptation 1 of cortical MM2 sporadic CJD (MM2-sCJD) prions to tg338 mice exhibited differing tissue 2 tropism. T2 Ov replicated dominantly in the brain with T1 Ov being present as a subcomponent, 3 while T1 Ov preferentially populated the spleen ([28] and Figure 5A-B) . A brain extract from 4 tg338-passaged MM2-sCJD prions (4 th passage) was inoculated by IC route to tg335 +/mice, prions, as based on the mean ID ( Figure 5A ), the PrP res signature in brain and spleen by 10 western blot ( Figure 5B ) and the neuroanatomical distribution of PrP res by histoblotting 11 ( Figure 5C ), which all showed the T1 Ov characteristics observed after infection with cloned 12 T1 Ov prions. The apparent counter-selection of T2 Ov prions in tg335 +/mice was not due to 13 their incapacity to replicate on low-expressor mice as bicloned T2 Ov prions elicited disease in 14 these mice in ~330 days ( Figure 5A ) with a T2 Ov -PrP res specific banding pattern in the brain 15 ( Figure 5B ) and presence of low levels of PrP res by histoblotting ( Figure 5C ). Together, these 16 data indicate that for another pair of co-propagating prion strains, there is a tight correlation 17 between capacity to replicate in the spleen and capacity to be dominantly expressed on mice 18 expressing low PrP C -levels in the brain. 19
Remarkably, the dominant expression of T1 Ov prions on passage of tg338-passaged MM2-20 sCJD prions to tg335 +/mice occurred to the detriment of T2 Ov prions. Over two serial back 21 passages to tg338 mice, T2 Ov prions were not phenotypically recovered. The T1 Ov signature 22 remained dominant in all brains and spleens from tg338 mice ( Figure 5A Building on our previous observations that the phenotypic expression of two prion 2 subcomponents present in variable proportions in numerous sheep scrapie isolates is driven by 3 PrP C expression levels in transgenic mice, we now show that the segregation between these 4 two agents occurs between the brain and the spleen of the same infected high-expressor 5 mouse, these tissues expressing different PrP C levels. Further, the replicative dominance in 6 the brain of a pair of strains derived from sporadic CJD prions with opposite tropism for the 7 brain and spleen appears tightly controlled by PrP C expression levels in transgenic mice 8 expressing varying PrP C levels. Host PrP C levels may thus impact prion (in)capacity to 9 replicate in the lymphoid tissue. with limited efficacy in the spleen, and thus were considered as mostly neurotropic. 20
That co-propagating TSE substrains replicate preferentially in distinct tissues from the same 21 host is not restricted to transgenic mice nor to the VRQ allele of ovine PrP. We show here a 22 similar enrichment of LA21K prions in the spleen relative to brain in the LAN-infected sheep. providing in vivo or ex vivo evidence (e.g., clearance of PrP Sc by macrophages). Here, we 20 firmly exclude this possibility as LA19K prions were not more sensitive than 127S prions to 21 either PK digestion or clearance by peritoneal macrophages (Figure 6 ). Aguilar-Calvo et al. 22
proposed that prion conformations could impact pathogenesis after peripheral infection, i.e., 23
highly fibrillar prion assemblies are poor neuroinvaders compared to subfibrillar prions but 24 high replicators in the spleen [31]. PrP Sc assemblies' particulate profile may indeed impact 25 access to the FDC from the site of infection [60, 61] . LA21K prions and vCJD prions would 1 follow this rule as they would be categorized as 'highly fibrillar', as based on their 2 sedimentation velocity profile and the presence of plaque-like deposits in the brain (this study 3 and [23, 62] ). However, T1 Ov and T2 Ov prions would escape such a rule as they exhibit similar 4 'subfibrillar' aggregation size [63] , despite distinct tropism for the spleen. 5
From the host viewpoint, mature FDC are necessary [9, 15-21, 64, 65] , being ontogenetically 6 present or induced by chronic inflammation [66] . Co-factors have been proposed to be 7 involved, including notably complement [67, 68], but the differential requirement amongst 8 strains is not known. Here, LA19K / LA21K prions preferential targeting for brain and spleen 9 correlated with PrP C expression levels in these tissues. The superimposable PrP C -dependent 10 selection obtained with a second pair of prion strains isolated from MM2-sCJD in tg338 mice 11
and showing differing tropism for the lymphoid versus the cerebral tissue, that is the most 12 lymphotropic is preferentially replicated on low-PrP C expressor mice and the most 13 neurotropic on high-PrP C expressor mice, further argues that PrP C expression levels may be a 14 major driver of prion (sub)strain selection in different tissues of the infected host. passage to tg338 mice, an outcome that was reminiscent of that observed during cross-species 22 transmission events (for reviews [7, 8] ). Such factors may be drivers of within-host prion 23 diversification/evolution during homotypic transmissions. 24
23
It may be noted that PrP C expression levels are classically quantified in the whole spleen and 1 in the whole brain, yet meaning that different variations in PrP C levels could occur locally in 2 prion-replicating cells [71] . The exact contribution of FDC to spleen PrP C expression level is 3 unknown due to the fact that these cells only account for 0.1-1% of the cells, making isolation 4 and quantification of their PrP C expression levels a highly challenging issue. However, we 5 previously reported by immunofluorescence that PrP C expression levels appeared low in 6
tg338 FDC compared to neurons [22] . 7 8 As a tentative explanation for strain-dependent polymerization rate as a function of PrP C levels, 9
we inferred by mathematical modelling that differences in the number of PrP C monomers 10 integrated in the growing PrP Sc assemblies (different kinetic order of the templating process) 11 could explain PrP C -dependent substrain selection [29] . LA19K growth would necessitate 12 integration of more PrP C molecules than for LA21K prions. In theory, the strain necessitating 13 more PrP C to replicate should also start accumulating in the spleen. However, the plateau of 14 tg338 mice remained PrP res -negative in the brain while their spleen was strongly and early 24 positive. This suggests an impaired capacity of LA21K prions to establish at full attack rate in 25 24 the brain, as previously observed with other prion types [23, 24] . Bicloned LA19K prions were 1 able to establish in the brain after IP infection, despite absence of replication in the spleen, by 2 a direct neuroinvasion process. However, direct neuroinvasion after IP infection usually results 3 in ID similar to those observed after primo-replication in the spleen [20, 21] . This suggests that 4 the IC versus IP ID was also aberrantly prolonged for bicloned LA19K prions. Comparison of 5 ID on low-versus high-expressors after inoculation of LA21K fast versus LA19K prions show 6 'abnormal' prolongation of ID for the latter [29] . It is therefore likely that PrP C -limiting events 7 are similarly occurring in high-expressor mice during prion neuroinvasion after IP inoculation. 8
Of note, when LAN404 sheep spleen instead of brain was transmitted to tg338 mice, the IP 9 versus IC injection delay observed (x1.47, Figure 4 ) was rather consistent with the ~1.3 value 10 found in other experimental models [50-53] and with PG127 in tg338 mice (Figure 3 ). As the 11 sheep spleen is less enriched than the brain in LA19K prions, these data would collectively 12 suggest that LA19K prions give the disease tempo after IP infection even if LA21K PrP res 13 molecular signature prions can be dominant. 14
15
In conclusion, these data and our previous report [29] suggest an emerging contribution of PrP 16 as a molecular driver/modulator of within-host prion selection. Events similar to the 17 brain/spleen segregation observed here could also occur directly within the brain owing to the 18 regional heterogeneity in PrP C levels and conformations in this tissue [74] . From a diagnostic 19 point of view, given the apparent complexity of natural animal and human TSE isolates in terms 20 of substrain heterogeneity [27, 75, 76] , these data advocate to type extraneural tissues or fluids 21 for a comprehensive identification of the TSE agents circulating in susceptible mammals. CH1641-like groups, at the terminal stage of disease. The spleen and the brain from 23 the same animal are presented, meaning that the brain can harbor a 21K or 19K PrP res 24 signature whereas a unique 21K signature is detected in the spleen. The spleen PrP res 25 28 profiles are also shown at early time points post-inoculation (from 50 to 200 days 1 depending on the isolate, Supplemental Table S2 ). Patterns after PG127 infection are 2 shown for comparison. 3 C) Representative immunoblot showing PrP res electrophoretic pattern in brain and spleen 4 from tg338 high-expressor mice inoculated IP with LA19K prions (4 th IC-brain-5 passage (4p), 6 th IC-brain-passage (6p) and cloned (cl)), at the terminal stage of 6 disease. The spleen and the brain from the same animal are presented, meaning that 7 the brain can harbor a 21K or 19K PrP res signature (with the 6 th pass, a double 21/19K 8 signature was observed) whereas a unique 21K signature is detected in the spleen The 9
spleen PrP res profiles are also shown at early time points post-inoculation (from 20 to 10 50 days depending on the number of passages, Supplemental Table S2 ). Patterns after 11 PG127 infection are shown for comparison. 12 
